Effectiveness of Percutaneous Pulley Release With Infiltration, Versus Infiltration Alone in Trigger Finders

Trigger finger is a mechanical problem characterized by pain and catching of digit in flexion.

Histological changes of A1 pulley and synovial proliferation have been identified as factors that prompt trigger finger The first-line treatment of trigger finger is conservative with splinting and corticosteroid injection.

If the first infiltration fails, either a second infiltration or surgical sectioning of the pulley is proposed.

Surgery can be performed by several techniques (open section, percutaneous section with palpatory guidance, or under ultrasound guidance).

Percutaneous A1 pulley release under ultrasound guidance consists of cutting the A1 pulley by a percutaneous insertion with small needle under local anaesthesia.

The hypothesis of the study is that percutaneous A1 pulley release under ultrasound guidance followed by a corticosteroid injection would be more effective than a second corticosteroid injection alone on complete resolution of the trigger finger symptoms

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Trigger Finger Muscular Diseases Musculoskeletal Diseases Tendinopathy Tendon Entrapment Trigger Finger Disorder

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hopital Henri Mondor, Créteil, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient ≥ 18 years old,
Presence of a trigger finger (thumb or long fingers) to be treated
Quinnell score >1
Episode of trigger characterized on questioning or clinical examination
Failure of a first corticosteroid infiltration > 3 months before inclusion
First infiltration within 15 months of inclusion
Thickening A1 pulley on ultrasound ≥ 0.5 mm
Patient who has the capacity to understand the protocol and has given consent to participate in the research,
Patient with social security coverage

Exclusion criteria

Presence of several symptomatic fingers requiring treatment by ultrasound-guided section of the pulley
Patient who are pregnant, breastfeeding, or who have the potential to become pregnant without effective contraception at the time of inclusion
Known allergy to corticoid (Hydrocortancyl®) including its excipients ((benzyl alcohol, sodium carmellose, sodium chloride, polysorbate 80)
Known allergies to lidocaine
Ongoing anticoagulant treatments (AVK, New Oral Anti-Coagulants)
Local or general infection, or suspicion of infection
Live vaccines
Evolving viruses (hepatitis, herpes, varicella, shingles)
Severe or uncontrolled hypertension
Unbalanced diabetes
Underlying progressive cardiovascular disease
Hemodialysis patients
Prosthesis on the finger to be treated
Echographic tendon fissure
Inflammatory disease (rheumatoid arthritis, spondyloarthritis, connective tissue diseases, etc.) with tenosynovitis.
History of surgery on the fingers
Dupuytren's disease
Patient participating in another interventional clinical research protocol involving a drug or medical device
Patient under guardianship, curators or legal protection

Treatment and study plan

Percutaneous A1 Pulley Release Under Ultrasound Guidance

Procedure

the A1 pulley is cut off with Ultrasound guidance by a percutaneous insertion of the small needle under local anaesthesia.

Corticosteroid injection

Drug

corticosteroid injection is performed

Primary outcomes

Effectiveness of pulley section with ultrasound guidance combined with corticosteroid infiltration versus corticosteroid alone on complete resolution of trigger finger's symptoms

Time frame: 1 year postoperatively

Trigger finger's symptoms defined by a clinical Quinnell score ≤1 without the use of an alternative therapy

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Departemental Vendee

Other

Registry information

Official study title

Effectiveness of Percutaneous A1 Pulley Release Under Ultrasound Guidance Associated With Infiltration, Versus Infiltration Alone, in Patients With Trigger Finders Who Have Failed a First Infiltration: a Randomized Controlled Trial

Acronym: SECOIA

Important dates

Study start: 2022
Primary completion: 2026
Study completion: 2027
First posted: Sep 16, 2021
Registry last updated: Jun 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting